NCT05892549

Brief Summary

In some clinical forms of COVID-19, an uncontrolled hyper-inflammatory reaction known as a "cytokine storm" appears abruptly, around day 7, and is associated with rapid respiratory deterioration, requiring hospitalization in an intensive care unit (ICU). At present, although risk factors for this severe form have been described, there are no validated criteria for determining which individual patients will develop this aggravation. The study of respiratory sounds (amplitude, frequency, ...) has made it possible in other respiratory pathologies (e.g., chronic obstructive pulmonary disease) to predict exacerbations several days in advance. Having a predictive respiratory pattern for worsening in COVID-19 would make it possible to anticipate the need for intensive care hospital beds, by means of a tool easily available on a mobile phone.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,188

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Jun 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Jun 2023Jul 2026

First Submitted

Initial submission to the registry

June 6, 2023

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 7, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

June 12, 2023

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

June 15, 2023

Status Verified

June 1, 2023

Enrollment Period

3.1 years

First QC Date

June 6, 2023

Last Update Submit

June 13, 2023

Conditions

Keywords

Voice

Outcome Measures

Primary Outcomes (2)

  • Sensitivity of the respiratory pattern demonstrated in the COVID patients who experienced respiratory worsening

    Through study completion (36 months)

  • Specificity of the respiratory pattern demonstrated in the COVID patients who experienced respiratory worsening

    Through study completion (36 months)

Study Arms (3)

COVID

Device: COVOICE application use - follow-up

Other respiratory diseases

Device: COVOICE application use - follow-up

Healthy

Device: COVOICE application use - initial

Interventions

Recording (only once) of sound related to respiratory movements, coughing and voice using a mobile phone application

Healthy

Daily recording of sound related to respiratory movements, coughing and voice using a mobile phone application. Duration: up to 30 days

COVIDOther respiratory diseases

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population is composed of people coming to a hospital or to a COVID screening center.

You may qualify if:

  • French speaking
  • Affiliated to a social security system
  • Owning a mobile phone capable of accessing the COVOICE application

You may not qualify if:

  • Incapable adults
  • People deprived of their liberty
  • People under administrative or judicial supervision
  • Patients intubated or hospitalized in intensive care unit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital d'Instruction des Armées Bégin

Saint-Mandé, 94160, France

RECRUITING

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2023

First Posted

June 7, 2023

Study Start

June 12, 2023

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

June 15, 2023

Record last verified: 2023-06

Locations